Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Absorbable Stent for Blocked Leg Arteries

By HospiMedica staff writers
Posted on 21 Feb 2005
After initial use to prop open a leg artery, a new metal stent is absorbed when it is no longer needed.

This is the first bioabsorbable metal stent tested in humans. More...
It is made of an alloy of 90% magnesium and 10% rare earth elements. An absorbable polymer stent has been tested but does not appear to be as effective as the metal stent in propping open the artery.

Stents are a minimally invasive alternative to surgery to open up arteries in the heart and legs that have become blocked with plaque. However, depending on the implant locations, up to 40% of the time, arteries reclog, a process called restenosis. One cause of restenosis is recurrent inflammation prompted by the stent itself. Once absorbed, the resorbable metal stent no longer inflames the blood vessel, theoretically reducing restenosis.

The new absorbable metal stent is completely absorbed into the vessel wall without freeing particles into the blood stream. As soon as it is in place, the body begins to cover it with a layer of cells and then the vessel wall begins absorbing the stent. This process begins within a week to 10 days and the stent is fully absorbed within 60 days. In a study of 20 patients who received absorbable metal stents to treat blocked arteries below the knee, 15 of 19 (79%) remained open. Usually, only about 60% of narrowed below-the-knee arteries treated with standard stents remain open after six months. The study results were presented at the International Symposium on Endovascular Therapy in January 2005 in Miami Beach (FL, USA).

"A stent is really only needed for a couple of weeks, to allow the blood vessel to reshape and get strong, and after time it is useless,” pointed out Marc Bosiers, M.D., lead author of the study and head of the department of vascular surgery at A.Z. Sint-Blasius Hospital (Dendermonde, Belgium). "We believe the absorbable metal stent
could be a major breakthrough, because it provides a temporary solution to a temporary problem.”




Related Links:
A.Z. Sint-Blasius Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.